Finance

Lists
SIGHT:EPA
Gensight Biologics SA
0,069 €
+0,29%
(+0,00020) 1D
6-ноя., 17:35:13 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SIGHT...
Open
0,07 €
High
0,07 €
Low
0,07 €
Mkt. cap
17,64 млн
Avg. vol.
1,45 млн
Volume
148,30 миң
52-wk high
0,15 €
52-wk low
0,06 €
EPS
-0,08 €
Shares outstanding
246,22 млн
No. of employees
18
Open
0,07 €
High
0,07 €
Low
0,07 €
Mkt. cap
17,64 млн
Avg. vol.
1,45 млн
Volume
148,30 миң
52-wk high
0,15 €
52-wk low
0,06 €
EPS
-0,08 €
Shares outstanding
246,22 млн
No. of employees
18
News stories
From web sources and news partners
About Gensight Biologics SA
CEO-
Employees18
Founded2012
HeadquartersПариж, Иль-де-Франция, Франция
SectorHealth Care
Industry-
Websitegensight-biologics.com
Last report
2026-ж., 8-июл.
Fiscal period
Q2 2026
- / -
Revenue / Est. (EUR)
-428,00 миң / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
302,00 миң
302,00 миң
-428,00 миң
-428,00 миң
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,08 млн
1,08 млн
2,34 млн
2,34 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,36 млн
1,36 млн
1,50 млн
1,50 млн
Operating expense
2,43 млн
2,43 млн
3,84 млн
3,84 млн
Total operating expenses
2,43 млн
2,43 млн
3,84 млн
3,84 млн
Operating income
-2,13 млн
-2,13 млн
-4,27 млн
-4,27 млн
Other non operating income
436,00 миң
436,00 миң
-285,50 миң
-285,50 миң
EBT including unusual items
-2,53 млн
-2,53 млн
-5,14 млн
-5,14 млн
EBT excluding unusual items
-2,53 млн
-2,53 млн
-5,14 млн
-5,14 млн
Income tax expense
2,00 миң
2,00 миң
500,00
500,00
Effective tax rate
-0,08%
-0,08%
-0,01%
-0,01%
Other operating expenses
-
-
-
-
Net income
-2,53 млн
-2,53 млн
-5,14 млн
-5,14 млн
Net profit margin
-839,24%
-839,24%
1 199,88%
1 199,88%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-784,50 миң
-784,50 миң
-578,00 миң
-578,00 миң
Net interest expenses
-784,50 миң
-784,50 миң
-578,00 миң
-578,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,09 млн
-2,09 млн
-4,24 млн
-4,24 млн
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору